Cellbion Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
00:23
Feb 05
Feb 05
US obesity strength lifts Korean biotech
US healthcare and Eli Lilly strength should keep momentum in obesity treatments, and the speaker lists Korean biotech and obesity-related names such as D&D Pharmatech, Samyang Biopharm, April Bio, Ildong Pharmaceutical, Celltrion Pharm, Aimed Bio, Cellbion and Inventage as market movers.
MED
About Cellbion Investor Commentary
Across the available history and selected sources, Buzzberg tracks Cellbion across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Min Jae-gi.